Insulin-like growth factor-I in liver cirrhosis

This publication has 51 references indexed in Scilit:

• Low doses of insulin-like growth factor-I improve nitrogen retention and food efficiency in rats with early cirrhosis
  Journal of Hepatology, 1997
• Insulin-like growth factor I is an independent coregulatory modulator of natural killer (NK) cell activity
  Endocrinology, 1996
• Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-alpha production
  Endocrinology, 1996
• Insulin-like growth factor I as a predictor of cortical bone mass in a long-term study of ovariectomized and estrogen-treated rats
  Bone, 1996
• High Insulin–Like Growth Factor Binding Protein 1 Levels in Cirrhosis: Link With Insulin Resistance
  Hepatology, 1996
• Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome
  Journal of Clinical Endocrinology & Metabolism, 1994
• Spontaneous bacterial peritonitis is associated with high levels of interleukin‐6 and its secondary mediators in ascitic fluid
  European Journal of Clinical Investigation, 1993
• Regulation of insulin-like growth factor binding protein-3 messenger ribonucleic acid expression by insulin-like growth factor I
  Endocrinology, 1992
• The Effects of Treatment with Recombinant Human Growth Hormone on Body Composition and Metabolism in Adults with Growth Hormone Deficiency
  New England Journal of Medicine, 1989
• Short-Term Metabolic Effects of Recombinant Human Insulin-like Growth Factor I in Healthy Adults
  New England Journal of Medicine, 1987